Skip to content
HomeHeart disease

Heart disease

5 things we now know about atrial fibrillation

More than 37.5 million people worldwide are affected by this common type of heart arrhythmia—and by 2050, the number of cases will increase by 60%. For American Heart Month, learn the facts behind this heart condition, plus one patient’s diagnosis story.

5 things we now know about peripheral artery disease

The common circulatory condition is a leading cause of amputations in the U.S. Learn why Black Americans are disproportionately affected and how Johnson & Johnson is helping to raise awareness about the disease.

Advancing diversity: 3 healthcare experts share their career stories

The statistics are stark: People of color are vastly underrepresented in medical and scientific professions. But various programs—including ones sponsored by Johnson & Johnson—are working to help level the playing field.

3 smart tech tools that help diagnose pulmonary arterial hypertension

In many cases, it can take more than two years to diagnose this rare disease—and that delay can be deadly. For Pulmonary Hypertension Awareness Month, learn why Johnson & Johnson is on a mission to identify patients earlier by harnessing the power of artificial intelligence, smartphone apps and more.

4 things scientists now know about autoimmune diseases in kids

Two experts in the field share the latest understanding and research into conditions like pediatric plaque psoriasis, juvenile idiopathic arthritis and pediatric active psoriatic arthritis—diseases that afflict children and can have long-term damaging effects into adulthood if not properly treated.

4 things we now know about the rare disease AL amyloidosis

Imagine having a disease that many doctors have never seen before. That’s what Marty Verel experienced when he was told he had AL amyloidosis—and it’s what hematologist Brendan Weiss, M.D., is determined to help change. For Rare Disease Day, Dr. Weiss shares what he’s learned studying the rare disease.

3 eye-opening statistics about racial inequities in heart health among Black Americans

Black people are far more likely to live with cardiovascular diseases than other populations in the United States. We spoke to three experts about the consequences of that disparity—and how Johnson & Johnson is actively working to help drive change and better heart health through improved education, diagnosis and treatment.

Driving change: How Johnson & Johnson is using mobile healthcare to help address health inequities across the U.S.

From churches to schools—and even roving healthcare vans—the company has rolled out a program in states across the nation to help get COVID-19 testing and other crucial health services to underserved communities.

She oversees one of the world’s largest healthcare businesses: 7 questions for Ashley McEvoy in the time of COVID-19

Johnson & Johnson develops consumer products, medical devices and pharmaceuticals—and McEvoy is at the helm of its global Medical Devices Companies. She shares how she has navigated the pandemic, grown professionally and personally as a result, and helped impact the lives of millions during this unique moment in history.

Is it really safe to go to the doctor during a pandemic? Listen to what this M.D. has to say

Have you been putting off medical care this year out of concern about COVID-19? We asked a triple board-certified physician to share his best advice—and info about a new digital resource called My Health Can’t Wait—for how to ensure you aren’t putting your health at risk by waiting to schedule healthcare visits.